Barinthus Biotherapeutics plc (BRNS)

Barinthus Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	86.26	110.66	142.09	194.39	214.05	43.27
Cash & Short-Term Investments	86.26	110.66	142.09	194.39	214.05	43.27
Cash Growth	-26.76%	-22.12%	-26.90%	-9.19%	394.74%	278.46%
Accounts Receivable	-	-	-	5.85	0.02	0.52
Other Receivables	5.01	7.14	7.94	6.31	6.93	3.01
Receivables	5.01	7.14	7.94	12.16	6.95	3.53
Prepaid Expenses	6.35	5.86	5.4	5.89	4.61	1.08
Restricted Cash	1.53	1.74	-	-	-	-
Other Current Assets	1.27	0.34	1.47	0.61	1.15	0.03
Total Current Assets	100.41	125.74	156.91	213.04	226.77	47.9
Property, Plant & Equipment	7.84	11.76	19.4	15.71	9.09	2.77
Goodwill	-	-	12.21	12.21	12.63	-
Other Intangible Assets	20.37	21.95	25.11	28.27	31.43	-
Other Long-Term Assets	0.94	0.88	0.88	0.98	0.8	-
Total Assets	129.56	160.33	214.51	270.21	280.72	50.67
Accounts Payable	1.8	2.47	1.6	3.75	2.42	4.67
Accrued Expenses	7.36	9.53	9.21	8.06	7.88	2.54
Short-Term Debt	-	-	-	-	0.16	-
Current Portion of Leases	2.04	1.92	1.79	0.43	0.52	0.19
Current Unearned Revenue	1.53	1.74	-	-	0.18	0.25
Total Current Liabilities	12.73	15.66	12.6	12.24	11.16	7.64
Long-Term Debt	-	-	-	-	-	44.7
Long-Term Leases	9.95	10.09	11.19	8.34	6.54	1.47
Long-Term Deferred Tax Liabilities	0.39	0.44	0.57	3.75	8.08	-
Other Long-Term Liabilities	4.01	4.01	3.15	2.68	2.37	-
Total Liabilities	27.08	30.19	27.51	27	28.15	53.81
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	393.66	393.47	386.6	379.5	369.1	21.66
Retained Earnings	-278.44	-237.66	-176.59	-103.24	-108.59	-57.72
Comprehensive Income & Other	-12.85	-25.78	-23.23	-33.37	-8.39	-1.24
Total Common Equity	102.38	130.03	186.78	242.9	252.13	-37.3
Minority Interest	0.1	0.11	0.21	0.31	0.44	0.39
Shareholders' Equity	102.48	130.14	187	243.2	252.56	-3.15
Total Liabilities & Equity	129.56	160.33	214.51	270.21	280.72	50.67
Total Debt	11.99	12.01	12.98	8.77	7.22	46.36
Net Cash (Debt)	74.27	98.66	129.11	185.61	206.83	-3.1
Net Cash Growth	-29.40%	-23.59%	-30.44%	-10.26%	-	-
Net Cash Per Share	1.85	2.51	3.36	4.86	7.99	-0.39
Filing Date Shares Outstanding	40.72	40.34	38.92	38.34	37.19	0.03
Total Common Shares Outstanding	40.35	40.23	38.64	37.68	37.19	0.03
Working Capital	87.69	110.09	144.31	200.8	215.61	40.26
Book Value Per Share	2.54	3.23	4.83	6.45	6.78	-1447.99
Tangible Book Value	82.01	108.08	149.47	202.42	208.07	-37.3
Tangible Book Value Per Share	2.03	2.69	3.87	5.37	5.59	-1447.99
Machinery	-	7.51	6.84	5.35	2.09	1.06
Leasehold Improvements	-	9.28	8.67	3.93	0.63	0.05

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q